Immunic, Inc
Price
FilingsNewest: 8-K, Director or officer changeSep 11 →InsidersNo open-market buys or sales.→HoldersAberdeen 6.0%BVF Inc/il 5.6%Millennium 5.4%→Financing →PeersClosest companies: JSPR, PDSB, CNSP→
From the filings
Figures
- Net income
- −$111.6Mlast 12 months
- Operating cash flow
- −$81.3Mlast 12 months
- Cash and equivalents
- $155.1Mat the last balance sheet
- Shares outstanding
- 13.6M shareson issue